<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01669889</url>
  </required_header>
  <id_info>
    <org_study_id>BP28421</org_study_id>
    <nct_id>NCT01669889</nct_id>
  </id_info>
  <brief_title>A Non-Drug Study on the Relationship Between Exploratory Biomarkers and Functional Dimensions in Individuals With Autistic Disorder or Asperger's Syndrome</brief_title>
  <official_title>A Multi-center, Non-drug Study to Explore the Relationship Between Exploratory Biomarkers and Functional Dimensions in Individuals With Autistic Disorder or Asperger's Syndrome.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hoffmann-La Roche</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hoffmann-La Roche</source>
  <brief_summary>
    <textblock>
      This multi-center, non-drug study will explore the relationship between exploratory
      biomarkers and functional dimensions in male adult individuals with Autistic Disorder or
      Asperger's Syndrome and healthy volunteer controls. Subjects will undergo a number of
      assessments on study visit Day 1.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Behavior assessment ratings</measure>
    <time_frame>approximately 5 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cognition assessment ratings</measure>
    <time_frame>approximately 5 months</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">38</enrollment>
  <condition>Healthy Volunteer, Autistic Disorder, Asperger's Syndrome</condition>
  <arm_group>
    <arm_group_label>Cohort</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        High functioning (IQ &gt;70) male adult individuals with Autistic Disorder or Asperger's
        Syndrome and age and IQ matched healthy male volunteers
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Individuals with Autistic Disorder or Asperger's Syndrome:

          -  Male adults, 18 to 45 years of age inclusive

          -  Diagnosis of Autistic Disorder or Asperger's Syndrome as defined by DSM-IV

          -  IQ &gt;70

          -  Body mass index (BMI) 18 to 35 kg/m2

          -  Availability of a reliable caregiver, able and willing to provide information
             regarding the individual's behavior and symptoms

        Healthy controls:

          -  Healthy male adults, 18 to 45 years of age inclusive

          -  IQ &gt;70

          -  Body mass index (BMI) 18 to 30 kg/m2

        Exclusion Criteria:

        General exclusion criteria:

          -  Positive test for drugs of abuse or alcohol

          -  Confirmed systolic blood pressure &gt;140 or &lt;90 mmHg, and diastolic blood pressure &gt;90
             or &lt;50 mmHg

          -  Resting pulse rate &gt;100 or &lt;40 beats per minute

          -  Alcohol and/or substance abuse/dependence during the last 12 months

          -  Concomitant disease or condition that could interfere with, or treatment of which
             might interfere with, the conduct of the study, or that would, in the opinion of the
             investigator, pose an unacceptable risk to the subject in this study

        Additionally for individuals with Autistic Disorder or Asperger's Syndrome:

          -  History of epilepsy/seizure disorder (except simple febrile seizures)

               -  Significant disruptive, aggressive or self-injurious, or sexually inappropriate
                  behavior during the last 3 months that in the opinion of the investigator might
                  interfere with the conduct of the study

        Additionally for healthy controls:

          -  Clinically significant abnormalities in laboratory test results

          -  History of or current psychiatric, neurological disorder or pervasive developmental
             disorder
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clinical Trials</last_name>
    <role>Study Director</role>
    <affiliation>Hoffmann-La Roche</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Los Ageles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 15, 2012</study_first_submitted>
  <study_first_submitted_qc>August 17, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 21, 2012</study_first_posted>
  <last_update_submitted>November 1, 2016</last_update_submitted>
  <last_update_submitted_qc>November 1, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 2, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Autistic Disorder</mesh_term>
    <mesh_term>Asperger Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

